Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
United States: Food and Drug Administration
598-CL-004
NCT00050297
February 2004
Name | Location |
---|